Article Versions Notes

Vlacic G, Hoda MA, Klikovits T, Sinn K, Gschwandtner E, Mohorcic K, Schelch K, Pirker C, Peter-Vörösmarty B, Brankovic J, et al. Expression of FGFR1–4 in Malignant Pleural Mesothelioma Tissue and Corresponding Cell Lines and its Relationship to Patient Survival and FGFR Inhibitor Sensitivity. Cells. 2019; 8(9):1091. https://doi.org/10.3390/cells8091091

Vlacic, Gregor, Mir A. Hoda, Thomas Klikovits, Katharina Sinn, Elisabeth Gschwandtner, Katja Mohorcic, Karin Schelch, Christine Pirker, Barbara Peter-Vörösmarty, Jelena Brankovic, and et al. 2019. "Expression of FGFR1–4 in Malignant Pleural Mesothelioma Tissue and Corresponding Cell Lines and its Relationship to Patient Survival and FGFR Inhibitor Sensitivity" Cells 8, no. 9: 1091. https://doi.org/10.3390/cells8091091

Vlacic, G., Hoda, M. A., Klikovits, T., Sinn, K., Gschwandtner, E., Mohorcic, K., Schelch, K., Pirker, C., Peter-Vörösmarty, B., Brankovic, J., Dome, B., Laszlo, V., Cufer, T., Rozman, A., Klepetko, W., Grasl-Kraupp, B., Hegedus, B., Berger, W., Kern, I., & Grusch, M. (2019). Expression of FGFR1–4 in Malignant Pleural Mesothelioma Tissue and Corresponding Cell Lines and its Relationship to Patient Survival and FGFR Inhibitor Sensitivity. Cells, 8(9), 1091. https://doi.org/10.3390/cells8091091